Janssen Pharmaceutica

Part of Johnson & Johnson (Wikidata)

Organisation

Part of

NCT06505369
Collaborator, Phase 2, Recruiting, 2024, 50 people, 17 Jul 2024, clinicaltrials.gov
NCT06353022
Collaborator, Phase 2, Active, not recruiting, 2024, 103 people, 8 Apr 2024, clinicaltrials.gov
NCT06189833
Collaborator, Phase 2, Status unknown, 2023, 200 people, 5 Jan 2024, clinicaltrials.gov
NCT04592237
Collaborator, Phase 2, Active, not recruiting, 2020, 120 people, 19 Oct 2020, clinicaltrials.gov
NCT04183738
Collaborator, Phase 4, Withdrawn, 2021, 0 people, 3 Dec 2019, clinicaltrials.gov
NCT04131309
Collaborator, Phase 2, Completed, 2019, 40 people, 18 Oct 2019, clinicaltrials.gov
NCT03746652
Collaborator, Phase 2, Status unknown, 2018, 50 people, 20 Nov 2018, clinicaltrials.gov
NCT03141671
Collaborator, Phase 2, Status unknown, 2017, 345 people, 5 May 2017, clinicaltrials.gov
NCT03017872
Collaborator, Phase 4, Status unknown, 2017, 831 people, 11 Jan 2017, clinicaltrials.gov
NCT01769339
Phase 4, Completed, 2009, 115 people, 16 Jan 2013, clinicaltrials.gov
NCT00179244
Collaborator, Phase 3, Completed, 2004, 30 people, 15 Sept 2005, clinicaltrials.gov